| Morna Rae Clement, MA-CCC-A | |
|
1020 Johnson Rd, Golden, CO 80401-6002 | |
| (720) 723-5092 | |
| Not Available |
| Full Name | Morna Rae Clement |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1020 Johnson Rd, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205855897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Morna Rae Clement, MA-CCC-A 1055 Clermont St, #126, Denver, CO 80220-3808 Ph: (303) 399-8020 | Morna Rae Clement, MA-CCC-A 1020 Johnson Rd, Golden, CO 80401-6002 Ph: (720) 723-5092 |
News Archive
A meta-analysis of genome-wide association studies has identified six biological pathways that may be involved in the genetic predisposition to develop bipolar disorder.
Family companions who routinely accompany older adults to physician office visits could be helpful to health care quality improvement efforts, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
"The final communiques haven't been written. But the word on the street is that when leaders of the Group of 8 industrialized countries meet in France this week, they will claim that wealthy countries have come close to fulfilling their 2005 promise to boost annual development aid by $50 billion by 2010. They are not even in the ballpark," a New York Times editorial states, before noting data from the Organization for Economic Cooperation and Development showing that aid fell $19 billion short of that goal.
The final results of a six-month, multi-center, open-label Phase 3 study of VIAject® (more-rapid-acting injectable human insulin) versus regular human insulin (RHI) in 471 patients with type 2 diabetes were presented today by Helena Rodbard, M.D., at the 70th Scientific Sessions of the American Diabetes Association. Dr. Rodbard was a principal investigator of this study, which was designed to evaluate the safety and efficacy of VIAject® versus regular human insulin when used in combination with insulin glargine.
› Verified 5 days ago
Daniel Stephen Talian, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1030 Johnson Rd Ste 180, Golden, CO 80401 Phone: 720-744-0114 Fax: 720-442-8284 | |
Dr. Kenneth W Gabler, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Johnson Rd, Golden, CO 80401 Phone: 720-723-5125 | |
Alison Labrec, Audiologist Medicare: Medicare Enrolled Practice Location: 1030 Johnson Rd Ste 130, Golden, CO 80401 Phone: 720-726-5838 | |
Dr. Caryn Perry, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 555 Corporate Cir, Golden, CO 80401 Phone: 720-497-2334 | |
Dr. Christopher Philip Mccarron, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1020 Johnson Rd, Golden, CO 80401 Phone: 720-723-5120 | |
Dr. Aspen Marie Gutknecht, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2801 Youngfield St Ste 100, Golden, CO 80401 Phone: 303-231-9118 |